Behçet's Disease: Symptoms, Diagnosis And Treatment

dc.creatorPostal M.
dc.creatorAppenzeller S.
dc.date2011
dc.date2015-06-30T20:31:28Z
dc.date2015-11-26T14:50:45Z
dc.date2015-06-30T20:31:28Z
dc.date2015-11-26T14:50:45Z
dc.date.accessioned2018-03-28T22:02:03Z
dc.date.available2018-03-28T22:02:03Z
dc.identifier9781617615528
dc.identifierAutoimmune Disorders: Symptoms, Diagnosis And Treatment. Nova Science Publishers, Inc., v. , n. , p. 229 - 248, 2011.
dc.identifier
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84892088082&partnerID=40&md5=eb5d8cb6a487e05505c6aad923f77d04
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/108227
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/108227
dc.identifier2-s2.0-84892088082
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1254252
dc.descriptionBehçet's disease (BD) is a chronic, relapsing, systemic vasculitis of unknown etiology with the clinical features of mucocutaneous lesions, ocular, vascular, articular, gastrointestinal, urogenital, pulmonary, and neurologic involvement. It is believed to be due to an auto-immune process triggered by an infectious or environmental agent in a genetically predisposed individual. HLA-B51 is the most strongly associated risk factor. The disease usually starts around the third decade of life. Mucocutaneous lesions figure prominently in the presentation and diagnosis, and may be considered the hallmarks of BD. Therefore, their recognition may permit earlier diagnosis and treatment. Although, the treatment has become much more effective in recent years, BD is still associated with severe morbidity and considerable mortality. The main aim of the treatment should be the prevention of irreversible organ damage. Therefore, close monitoring, early and appropriate treatment is mandatory to reduce morbidity and mortality. We will review symptoms, diagnosis and the current state of knowledge regarding the therapeutic approaches for BD. © 2011 Nova Science Publishers, Inc. All rights reserved.
dc.description
dc.description
dc.description229
dc.description248
dc.descriptionSakane, T., Takeno, M., Suzuki, N., Inaba, G., Behçet's disease (1999) N Engl J Med., 341, pp. 1284-1291
dc.descriptionCorreia, M., Barbedo, M., Vaio, T., Mota, M., Gonçalves, O., Valente, J., Behçet's disease-a contemporary review (2009) Journal of Autoimmunity., 32, pp. 178-188
dc.descriptionYurdakul, S., Hamuryudan, V., Yazici, H., Behçet's syndrome (2003) Curr Opin Rheumatol., 16, pp. 38-42
dc.descriptionEvereklioglu, C., Current concepts in the etiology and treatment of Behçets disease (2005) Surv Ophthalmol., 50, pp. 297-350
dc.descriptionSut, N., Seyahi, E., Yurdakul, S., Senocak, M., Yazici, H., A cost analysis of Behçet's syndrome in Turkey (2007) Rheumatology., 46, pp. 678-682
dc.descriptionKulaber, A., Tugal-Tutkun, I., Sibel, P., Pro-inflammatory cellular immune response in Behçet's disease (2007) RheumatolInt., 27, pp. 1113-1118
dc.descriptionAhmad, T., Wallace, G.R., James, T., Neville, M., Mapping the HLA association in Behçet's disease a role for tumor necrosis factor polymorphisms? (2003) Arthritis Rheum., 48, pp. 807-813
dc.descriptionAkman, A., Sallakci, N., Kacaroglu, H., Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease (2008) J Eur Acad Dermatol Venereol., 22, pp. 950-957
dc.descriptionVerity, D.H., Marr, J.E., Ohno, S., Behçet's disease
dc.descriptionthe Silk Road and HLA-B51, historical and geographical perspectives (1999) Tissue Antigens., 54, pp. 213-220
dc.descriptionKazi, S., Behçet's disease (2004) Encyclopedia of Gastroenterology., 3, pp. 169-171
dc.descriptionTugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Uveitis in Behcet disease: an analysis of 880 patients (2004) Am J Ophthalmol., 138, pp. 373-380
dc.descriptionTursen, U., Gurler, A., Boyvat, A., Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease (2003) Int J Dermatol., 42, pp. 346-351
dc.descriptionZouboulis, C.C., Epidemiology of Adamantiades-Behçet's disease (1999) Ann Med Interne., 150, pp. 488-498
dc.descriptionZouboulis, C.C., Kotter, I., Djawari, D., Epidemiological features of Adamantiades-Behcet's disease in Germany and in Europe (1997) Yonsei Med J., 38, pp. 411-422
dc.descriptionOshima, Y., Shimizu, T., Yokohari, R., Clinical studies on Behçet's syndrome (1963) Ann Rheum Dis., 22, pp. 36-45
dc.descriptionYazici, H., TüZün, Y., Pazarli, H., Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome (1984) Ann Rheum Dis., 43, pp. 783-789
dc.descriptionTsai, J., Chen, G.S., Lu, Y.W., Wu, C.S., Lan, C.C., Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients (2008) J Eur Acad Dermatol Venereol., 22, pp. 596-600
dc.descriptionSaricaoglu, H., Karadogan, K.S., Bayzazit, N., Clinical features of late-onset Behçet's disease: report of nine cases (2006) Int J Dermatol., 45, pp. 1284-1287
dc.descriptionPay, S., Simsek, I., Erdem, H., Dinç, A., Immunopathogenesis of Behçet's disease with special emphasize to the possible role of antigen presenting cells (2007) Rheumatol Int., 27, pp. 417-424
dc.descriptionDundar, S.V., Gencalp, U., Simsek, H., Familial cases of Behçet's disease (1985) Br J Dermatol., 113, pp. 319-321
dc.descriptionArber, N., Klein, T., Meiner, Z., Pras, E., Weinberger, A., Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome (1991) Ann Rheum Dis., 50, pp. 351-353
dc.descriptionAkpolat, T., Koc, Y., Yeniay, I., Akpek, G., Gullu, I., Kansu, E., Familial Behçet's disease (1992) European Journal of Medicine., 1, pp. 391-395
dc.descriptionNishiura, K., Kotake, S., Ichiishi, A., Matsuda, H., Familial occurrence of Behçet's disease (1996) Jpn J Ophthalmol., 40, pp. 255-259
dc.descriptionNishiyama, M., Nakae, K., Hashimoto, T., Inaba, G., Sakane, T., Recent epidemiological features of familial Behçet's disease in Japan (1996) Asian Medical Journal., 39, pp. 495-501
dc.descriptionShahram, F., Chams, C., Davatchi, F., Dadji, A., Akbarian, M., Jamshidi, A., Familial study in Behçet's disease
dc.descriptionanalysis of 1242 patients. 8th International Congress on Behçet's disease. October 7-9, 1998 (1998) Reggio Emilia
dc.descriptionItaly;., P9, p. 103
dc.descriptionFresko, I., Soy, M., Hamuryudan, V., Yurdakul, S., Yavuz, S., Tumer, Z., Genetic anticipation in Behçet's syndrome (1998) Ann Rheum Dis., 57, pp. 45-48
dc.descriptionYazici, H., Çiçek, B., Basaran, G., Hamuryudan, V., Cakir, N., Dimitriatris, I., Behçet'ssyndrome with emphasis on clinical genetics and mortality London: (1996) Chapman and Hall., pp. 199-206. , In: Ansell BM
dc.descriptionBacon PA
dc.descriptionLie JT
dc.descriptionYazici H
dc.descriptioneds. The vasculitides
dc.descriptionKoné-Paut, I., Geisler, I., Wechsler, B., Ozen, S., Ozdogan, H., Rozenbaum, M., Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands (1999) J Pediatr., 135, pp. 89-93
dc.descriptionAral, O., Dilsen, N., Konice, M., Positive skin pathergy reactivity as a genetic marker of Behçet'sdisease (1986) Royal Society of Medicine Services;., pp. 173-175. , In: Lehner T
dc.descriptionBarnes CG
dc.descriptioneds. Recent advances in Behçet'sdisease. London:
dc.descriptionChamberlain, M.A., A family study of Behcet's syndrome (1978) Ann Rheum Dis., 37, pp. 459-465
dc.descriptionBird Stewart, J.A., Genetic analysis of families of patients with Behçet's syndrome: data incompatible with autosomal recessive inheritance (1986) Ann Rheum Dis., 45, pp. 265-268
dc.descriptionGuo, S.W., Inflation of sibling recurrence risk-ratio
dc.descriptiondue to ascertainment bias and/or overreporting (1998) Am J Hum Genet., 63, pp. 252-258
dc.descriptionGü, L.A., Inanç, M., Öcal, L., Aral, L., Koniçe, M., Familial aggregation of Behçet's disease in Turkey (2000) Ann Rheum Dis., 59, pp. 622-625
dc.descriptionCoskun, M., Bacanli, A., Sallakci, N., Alpsoy, E., Yavuzer, U., Yegin, O., Specific interleukin-1 gene polymorphisms in Turkish patients with Behçet's disease (2005) Exp Dermatol., 14, pp. 124-129
dc.descriptionKarasneh, J., Hajeer, A.H., Barrett, J., Oliver, W.E., Thornhill, M., Gu, L.A., Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet'sdisease (2003) Rheumatology., 42, pp. 860-864
dc.descriptionBoiardi, L., Salvarani, C., Casali, B., Olivieri, I., Ciancio, G., Cantini, F., Intercellular adhesion molecule-1 gene polymorphisms in Behçet'sdisease (2001) J Rheumatol., 28, pp. 1283-1287
dc.descriptionVerity, D.H., Vaughan, R.W., Kondeatis, E., Madanat, W., Zureikat, H., Fayyard, F., Intercellular adhesion molecule-1 gene polymorphism in Behçet's disease (2000) Eur J Immunogenet., 27, pp. 73-76
dc.descriptionSalvarani, C., Boiardi, L., Casali, B., Olivieri, I., Ciancio, G., Cantini, F., Endothelial nitric oxide synthase gene polymorphisms in Behçet'sdisease (2002) J Rheumatol., 29, pp. 535-540
dc.descriptionAyesh, S., Abu-Rmaileh, H., Nassar, S., Molecular analysis of MEFV gene mutations among Palestinian patients with Behçet'sdisease (2008) Scand J Rheumatol., 37, pp. 370-374
dc.descriptionRabinovich, E., Shinar, Y., Leiba, M., Ehrenfeld, M., Langewitz, P., Livneh, A., Common FMF alleles may predispose to development of Behçet's disease with increased risk for venous thrombosis (2007) Scand J Rheumatol., 36, pp. 48-52
dc.descriptionImirzalioglu, N., Dursun, A., Tastan, B., Soysal, Y., Yakicier, M.C., MEFV gene is a probable susceptibility gene for Behçet's disease (2005) Scand J Rheumatol., 34, pp. 56-58
dc.descriptionLehner, T., The role of heat shock protein
dc.descriptionmicrobial and autoimmune agents in the aetiology of Behçet's disease (1997) Int Rev Immunol., 14, pp. 21-32
dc.descriptionDireskeneli, H., Behçet's disease: infectious aetiology
dc.descriptionnew autoantigens
dc.descriptionand HLA-B51 (2001) Ann Rheum Dis., 60, pp. 996-1002
dc.descriptionErgun, T., Ince, U., Eksioglu-Demiralp, E., HSP 60 expression in mucocutaneous lesions of Behçet's disease (2001) J Am Acad Dermatol., 45, pp. 904-909
dc.descriptionMusabak, U., Pay, S., Erdem, H., Simsek, I., Pekel, A., Dinc, A., Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations? (2006) Rheumatol Int., 26, pp. 545-550
dc.descriptionHamzaoui, K., Hamzaoui, A., Ghorbel, I., Khanfir, M., Houman, H., Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease (2006) Scand J Rheumatol., 64, pp. 655-660
dc.descriptionHouman, H., Hamzaoui, A., Ghorbel, I., Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations (2004) J Autoimmun., 23, pp. 267-273
dc.descriptionBank, I., Duvdevani, M., Livneh, A., Expansion of gd T-cells in Behcet's disease: role of disease activity and microbial flora in oral ulcers (2003) J Lab Clin Med., 141, pp. 33-40
dc.descriptionVerity, D.H., Wallace, G.R., Vaughan, R.W., Stanford, M.R., Behçet's disease-from Hippocrates to the third millennium (2003) Br J Ophthalmol., 87, pp. 1175-1183
dc.descriptionZierhut, M., Mizuki, N., Ohno, S., Inoko, L.H.G.A., Onoe, K., Immunology and functional genomics of Behçet's disease (2003) Cell Mol Life Sci., 60, pp. 1903-1922
dc.descriptionAlpsoy, E., Zouboulis, C.C., Ehrlich, C.E., Mucocutaneous lesions of Behçet's disease (2007) Yonsei Med. J, 48, pp. 573-585
dc.descriptionAlpsoy, E., Aktekin, M., Er, H., Durusoy, C., Yilmaz, E., A randomized
dc.descriptioncontrolled and blinded study of papulopustular lesions in Turkish Behcet's patients (1998) Int J Dermatol., 37, pp. 839-843
dc.descriptionAlpsoy, E., Donmez, L., Bacanli, A., Apaydin, C., Butun, B., Review of the clinical manifestations' chronology in 60 patients with Behçet's disease (2003) Dermatology., 117, pp. 354-356
dc.descriptionVerity, D.H., Wallace, G.R., Seed, P.T., Soluble adhesion molecules in Behcet's disease (1998) Ocul Immunol InXamm., 6, pp. 81-92
dc.descriptionNobuyoshi, K., Miyazaki, A., Iwata, D., Ohno, S., Stansford, M.R., Chams, H., Ocular features of Behçet's disease: an international collaborative study (2007) Br J Ophthalmol., 91, pp. 1579-1582
dc.descriptionKump, L.I., Moeller, K.L., Reed, G.F., Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute (2008) Can J Ophthalmol., 43, pp. 468-472
dc.descriptionAndo, K., Fujino, Y., Hijikata, K., Izawa, Y., Masuda, K., Epidemiological features and visual prognosis of Behçet's disease (1999) Jpn J Ophthalmol., 43, pp. 312-317
dc.descriptionYoshida, A., Kawashima, H., Motoyama, Y., Shibui, H., Kaburaki, T., Shimizu, K., Comparison of patients with Behçet's disease in the 1980s and 1990s (2004) Ophthalmology., 111, pp. 810-815
dc.descriptionMarshall, S., Behçet's disease (2004) Best Pract Res Clin Rheumatol., 18, pp. 291-311
dc.descriptionKump, L.I., Moeller, K.L., Reed, G.F., Kurup, S.K., Nussenblatt, R.B., Levy-Clarke, G.A., Behçet'sdisease: comparing 3 decades of treatment response at the National Eye Institute (2008) Can J Ophthalmol., 43, pp. 468-472
dc.descriptionCriteria for diagnosis of Behçet'sdisease (1990) Lancet., 335, pp. 1078-1080. , International Study Group for Behçet'sDisease
dc.descriptionElgin, U., Berker, N., Batman, A., Incidence of secondary glaucoma in Behçet disease (2004) J Glaucoma., 13, pp. 441-444
dc.descriptionBadi, M.A.A., Zyani, M., Kaddouri, S., Niamane, R., Hda, A., Algayres, J.P., Les manifestations articulaires de la maladie de Behçet. Apropos de 79 cas (2007) Rev Med Interne., 29, pp. 277-282
dc.descriptionAtzeni, F., Sarzi-Puttini, P., Doria, A., Boiardi, L., Papitone, N., Salvarani, C., Behçet'sdisease and cardiovascular involvement (2005) Lupus., 14, pp. 723-726
dc.descriptionKural-Seyahi, E., Fresko, I., Seyahi, N., The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center (2003) Medicine Baltimore., 82, pp. 60-76
dc.descriptionGhorbel, I.B., Ennaifer, R., Lamloum, M., Budd-Chiari syndrome associated with Behçet'sdisease (2008) Gastroenterol Clin Biol., 32, pp. 316-320
dc.descriptionHamuryudan, V., Er, T., Seyahi, E., Akman, C., Tüzün, H., Fresko, I., Pulmonary artery aneurisms in Behçet'ssyndrome (2004) Am J Med., 117, pp. 867-870
dc.descriptionSeyahi, E., Hamuryudan, V., Hatemi, G., Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari syndrome) in 3 patients with Behçet'ssyndrome (2007) Rheumatology., 46, pp. 1213-1214
dc.descriptionGurgun, C., Ercan, E., Ceyhan, C., Yavuzgil, O., Zoghi, M., Aksu, K., Cardiovascular involvement in Behcet's disease (2002) Jpn Heart J., 43, pp. 389-398
dc.descriptionMorelli, S., Perrone, C., Ferrante, L., Cardiac involvement in Behçet's disease (1997) Cardiology., 88, pp. 513-517
dc.descriptionOzkan, M., Emel, O., Özdemir, M., M-Mode
dc.description2-D and Doppler echocardiography study in 65 patients with Behçet's syndrome (1992) Eur Heart J., 13, pp. 638-641
dc.descriptionYurdakul, S., Tuzuner, N., Yurdakul, I., Hamuryudan, V., Yazici, H., Gastrointestinal involvement in Behcet's syndrome: a controlled study (1996) Ann Rheum Dis., 55, p. 20810
dc.descriptionHassard, P.V., Binder, S.W., Nelson, V., Vasiliauskas, E.A., Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: a case report (2001) Gastroenterology., 120, pp. 995-999
dc.descriptionAkman-Demir, G., Serdaroglu, P., Tasçi, B., Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients (1999) Brain, 122, pp. 2171-2181
dc.descriptionBenamour, S., Naji, T., Alaoui, F.Z., El-Kabli, H., El-Aidouni, S., Neurological involvement in Behcet's disease. 154 cases from a cohort of 925 patients and review of the literature (2006) Rev Neurol., 162, pp. 1084-1090
dc.descriptionAl-Araji, A., Kidd, D.P., Neuro-Behçet's disease: epidemiology
dc.descriptionclinical characteristics
dc.descriptionand management (2009) Lancet Neurol., 8, pp. 192-204
dc.descriptionHentati, F., Fredj, M., Gharbi, N., Hamida, M., Clinical and biological aspects of neuro-Behçet's in Tunisia (1993) Elsevier., pp. 415-418. , In: Wechsler B
dc.descriptionGodeau P
dc.descriptioneds. Behçet's disease. Amsterdam
dc.descriptionLo Monaco, A., La Corte, R., Caniatti, L., Borrelli, M., Trotta, F., Neurological involvement in North Italian patients with Behset disease (2006) Rheumatol Int., 26, pp. 1113-1119
dc.descriptionBarros, R., Santos, E., Moreira, B., Clinical characterization and pattern of neurological involvement of Behçet's disease in fifteen Portuguese patients (2007) Clin Exp Rheumatol., 24 (SUPPL. 42), pp. S31
dc.descriptionJoseph, F.G., Scolding, N.J., Neuro-Behçet's disease in caucasians: a study of 22 patients (2007) Eur J Neurol., 14, pp. 174-180
dc.descriptionLee, S.H., Yoon, P.H., Park, S.J., Kim, D.I., MRI findings in neuro-Behçet's disease (2001) Clin Radiol., 56, pp. 485-494
dc.descriptionKural-Seyahi, E., Fresko, I., Seyahi, N., The long-term mortality and morbidity of Behset syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center (2003) Medicine Baltimore., 82, pp. 60-76
dc.descriptionHirohata, S., Histopathology of central nervous system lesions in Behçet's disease (2008) J Neurol Sci., 267, pp. 41-47
dc.descriptionHadfield, M.G., Aydin, F., Lippman, H.R., Kubal, W.S., Sanders, K.M., Neuro-Behçet's disease (1996) Clin Neuropathol., 15, pp. 249-255
dc.descriptionArai, Y., Kohno, S., Takahashi, Y., Miyajima, Y., Tsutusi, Y., Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation (2006) Neuropathology., 26, pp. 579-585
dc.descriptionScardamaglia, L., Desmond, P.M., Gonzales, M.F., Bendrups, A., Brotdmann, A., Kay, T.W.H., Behçet's disease with cerebral vasculitis (2001) Int Med J., 31, pp. 560-561
dc.descriptionLee, S.H., Yoon, P.H., Park, S.J., Kim, D.I., MRI fi ndings in neuro-Behçet's disease (2001) Clin Radiol., 56, pp. 485-494
dc.descriptionKoçer, N., Islak, C., Siva, A., CNS involvement in neuro-Behset syndrome: an MR study (1999) Am JNeuroradiol., 20, pp. 1015-1024
dc.descriptionSiva, A., Kantarci, O.H., Saip, S., Behçet's disease: diagnostic and prognostic aspects of neurological involvement (2001) J Neurol., 248, pp. 95-103
dc.descriptionYazici, H., Fresko, I., Yurdakul, S., Behçet's syndrome: disease manifestations
dc.descriptionmanagement
dc.descriptionand advances in treatment (2007) Nat Clin Pract Rheumatol., 3, pp. 148-155
dc.descriptionLeiba, M., Seligson, U., Sidi, Y., Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease (2004) Ann Rheum Dis., 63, pp. 1445-1449
dc.descriptionKidd, D., Steuer, A., Denman, A.M., Rudge, P., Neurological complications of Behçet's syndrome (1999) Brain., 122, pp. 2183-2194
dc.descriptionAl-Fahad, S., Al-Araji, A., Neuro-Behçet's disease in Iraq: a study of 40 patients (1999) J Neurol Sci., 170, pp. 105-111
dc.descriptionHouman, M.H., Neff Ati, H., Braham, A., Behçet's disease in Tunisia. Demographic
dc.descriptionclinical and genetic aspects in 260 patients (2007) Clin Exp Rheumatol., 25 (SUPPL. 45), pp. S58-64
dc.descriptionKermode, A.G., Plant, G.T., MacManus, D.G., Kendall, B.E., Kingsley, D.P.E., Moseley, I.F., Behçet's disease with slowly enlarging midbrain mass on MRI: resolution following steroid therapy (1989) Neurology., 39, pp. 1251-1252
dc.descriptionMason, R.M., Barnes, C.G., Behçet's syndrome with arthritis (1969) Ann Rheum Dis., 28, pp. 73-78
dc.descriptionMizushima, Y., Recent research into Behçet's disease in Japan (1988) Int J Tissue React., 10, pp. 59-65
dc.descriptionO'Duffy, J.D., Crite' res proposes pour la diagnostic maladie Beh$et et notes the' rapeutiques (1974) Rev Med Interne., 36, pp. 2371-2379
dc.descriptionRigby, A.S., Chamberlain, M.A., Bhakta, B., Behçet'sdisease (1995) Baillieres Clin Rheumatol., 9, pp. 375-395
dc.descriptionCriteria for diagnosis of Behçet'sdisease (1990) Lancet., 335, pp. 1078-1080. , International Study Group for Behçet'sdisease
dc.descriptionEvaluation of diagnostic (classification) criteria in Behçet'sdisease-towards internationally agreed criteria (1992) Br J Rheumatol., 31, pp. 299-308. , International Study Group for Behçet'sdisease
dc.descriptionRussell, A.I., Lawson, W.A., Haskard, D.O., Potential new therapeutic options in Behcet's syndrome (2001) BioDrugs., 15, pp. 25-35
dc.descriptionAlpsoy, E., Behçet'sdisease: treatment of mucocutaneous lesions (2005) Clin Exp Rheumatol., 23, pp. 532-539
dc.descriptionAlpsoy, E., Akman, A., Behçet's disease: an algorithmic approach to its treatment (2009) Arch Dermatol Res., 301, pp. 693-702
dc.descriptionConklin, R.J., Blasberg, B., Common inflammatory diseases of the mouth (1991) Int J Dermatol., 30, pp. 323-335
dc.descriptionSaxen, M.A., Ambrosius, W.T., Rehemtula Al, K.F., Russell, A.L., Eckert, G.J., Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized
dc.descriptiondouble-blind clinical trial (1997) Oral Surg Oral Med Oral Pathol Oral Radiol Endod., 84, pp. 356-361
dc.descriptionYurdakul, S., Mat, C., Tuzun, Y., Ozyazgan, Y., Hamuryudan, V., Uysal, O., A double-blind trial of colchicine in Behcet's syndrome (2001) Arthritis Rheum., 44, pp. 268-692
dc.descriptionSharquie, K.E., Najim, R.A., Abu-Raghif, A.R., Dapsone in Behcet's disease: a doubleblind
dc.descriptionplacebo-controlled
dc.descriptioncross-over study (2002) J Dermatol., 29, pp. 267-279
dc.descriptionHamuryudan, V., Mat, C., Saip, S., Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized
dc.descriptiondouble-blind
dc.descriptionplacebo-controlled trial (1998) Ann Intern Med., 128, pp. 443-450
dc.descriptionJorizzo, J.L., White, W.L., Wise, C.M., Zanolli, M.D., Sherertz, E.F., Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease (1991) J Am Acad Dermatol., 24, pp. 973-978
dc.descriptionKikuchi, H., Aramaki, K., Hirohata, S., Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years (2003) Adv Exp Med Biol., 528, pp. 575-578
dc.descriptionSuda, H., Low-dose weekly methotrexate therapy for progressive neuro-Behçet's disease (1999) Nihon Rinsho Meneki Gakkai Kaishi., 22, pp. 13-22
dc.descriptionDavatchi, F., Shahram, F., Chams, H., High dose methotrexate for ocular lesions of Behçet'sdisease. Preliminary shortterm results (2003) Adv Exp Med Biol., 528, pp. 579-584
dc.descriptionYazici, H., Pazarli, H., Barnes, C.G., A controlled trial of azathioprine in Behcet's syndrome (1990) N Engl J Med., 322, pp. 281-285
dc.descriptionDavatchi, F., Shahram, F., Chams, H., Akbarian, M., Pulse cyclophosphamide (PCP) for ocular lesions of Behçet's disease: double blind crossover study (1999) Arthritis Rheum., 42, pp. S320
dc.descriptionKötter, I., Günaydin, I., Batra, M., CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications-results of a retrospective analysis of 117 cases (2006) Clin Rheumatol., 25, pp. 482-486
dc.descriptionAdler, Y.D., Mansmann, U., Zouboulis, C.C., Mycophenolate mofetil is ineVective in the treatment of mucocutaneous Adamantiades-Behçet's disease (2001) Dermatology., 203, pp. 322-324
dc.descriptionPipitone, N., Olivieri, I., Cantini, F., Triolo, G., Salvarani, C., New approaches in the treatment of Adamantiades-Behcet's disease (2006) Curr Opin Rheumatol., 18, pp. 3-9
dc.descriptionLangford, C.A., Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases (2008) Nat Clin Pract Rheumatol., 4, pp. 364-370
dc.descriptionTugal-Tutkun, I., Mudun, A., Urgancioglu, M., Kamali, S., Kasapoglu, E., Inanc, M., Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine
dc.descriptioncyclosporine
dc.descriptionand corticosteroids in Behcet's disease: an open-label trial (2005) Arthritis Rheum., 52, pp. 2478-2484
dc.descriptionSfikakis, P.P., Behçet's disease: a new target for anti-tumour necrosis factor treatment (2002) Ann Rheum Dis., 61, pp. 51-53
dc.descriptionTriolo, G., Vadala, A., Accardo-Palumbo, A., Ferrante, A., Ciccia, F., Giardina, E., Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease (2002) Ann Rheum Dis., 61, pp. 560-561
dc.descriptionGulli, S., Arrigo, C., Bocchino, L., Morgante, L., Sangari, D., Castagna, I., Remission of Behçet's disease with anti-tumour necrosis factor monoclonal antibody therapy: a case report (2003) BMC Musculoskelet Disord., 4, p. 19
dc.descriptionOhno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Efficacy
dc.descriptionsafety
dc.descriptionand pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis (2004) J Rheumatol., 31, pp. 1362-1368
dc.descriptionMushtaq, B., Saeed, T., Situnayake, R.D., Murray, P.I., Adalimumab for sightthreatening uveitis in Behcet's disease (2007) Eye., 21, pp. 824-825
dc.descriptionFurst, D.E., Keystone, E.C., Kirkham, B., Kavanaugh, A., Fleischmann, R., Mease, P., Updated consensus statement on biological agents for the treatment of rheumatic diseases (2008) Ann Rheum Dis., 67, pp. 11122-5
dc.descriptionHatemi, G., Silman, A., Bang, D., EULAR recommendations for the management of Behset disease (2008) Ann Rheum Dis., 67, pp. 1656-1662
dc.languageen
dc.publisherNova Science Publishers, Inc.
dc.relationAutoimmune Disorders: Symptoms, Diagnosis and Treatment
dc.rightsfechado
dc.sourceScopus
dc.titleBehçet's Disease: Symptoms, Diagnosis And Treatment
dc.typeCapítulos de libros


Este ítem pertenece a la siguiente institución